Trilegal invites Ashwin Sapra to its equity partnership, strengthening its life sciences and healthcare capabilities

Mumbai, 05 January 2026: Trilegal, one of India’s leading law firms, has strengthened its life sciences and healthcare capabilities with the addition of seasoned lawyer Ashwin Sapra as an equity partner in the corporate practice. Ashwin brings over 25 years of domestic and international experience advising clients across the healthcare, pharmaceutical, medical device, diagnostics and life sciences sectors. With his joining, Trilegal’s partnership strength will increase to 151, reflecting its continued focus on building sector-specialised expertise.

As private capital, digital health initiatives, and regulatory reforms reshape India’s healthcare and life sciences sector, Trilegal’s strengthened leadership enhances its capabilities to advise industry participants and investors in navigating this evolving environment.

Commenting on the appointment, Nishant Parikh and Sridhar Gorthi, Partners and Members of the Management Committee at Trilegal, said, “Ashwin is a highly seasoned practitioner whose experience aligns well with the firm’s integrated, cross-practice model. He will play a key role in the firm’s rapidly growing healthcare, pharmaceutical, medical device and life sciences capabilities, adding depth and expertise to our client advisory competencies across transactional, disputes, regulatory, and intellectual property matters.”

On his joining, Ashwin Sapra said, “The healthcare sector in India is at an important stage of growth, with increased investment activity and regulatory engagement. Trilegal’s integrated platform, sector focus, and global standing provide an opportunity to work closely with clients on their most critical legal and business issues. I look forward to working with the team to support healthcare and life sciences clients across mandates.”

About Ashwin Sapra:
Ashwin Sapra brings over 25 years of domestic and international experience across pharmaceutical, medical devices, life sciences and healthcare transactions, disputes, advisory, intellectual property, and policy matters. He has successfully leveraged this expertise in a collaborative, cross-functional manner, offering strategic and commercially viable solutions that are synchronised with global and domestic best practices, experience-based foresight and client expectations. His deep subject-matter knowledge, industry insight, and strong professional relationships provide a competitive edge for organisations that are actively involved in advisory in this sector. Ashwin is widely recognised for his proficiency in regulatory compliance, disputes, medical device laws, clinical trial regulations, and IP strategy. He has extensive experience advising clients on complex issues related to drug approvals, drugs and medical device product liability, marketing practices/ anti-kickback laws, and IP portfolio management. Holding an LL.M. in Intellectual Property from Duke University, an LL.B. from Symbiosis Law College, and a B.Sc. in Zoology from Delhi University, Ashwin combines international exposure with a nuanced understanding of global and domestic regulatory frameworks and business practices. Frequently ranked by leading legal directories, he is a sought-after speaker and thought leader on healthcare policy, innovation, and emerging trends in life sciences and medical technology.

About Trilegal

Trilegal is a leading full-service law firm in India with over 25 years of experience, trusted for its in-depth expertise and client-centric approach. The firm advises a diverse set of clients, including Fortune 500 companies, global investment funds, major Indian conglomerates, domestic and international banks, technology and media giants, family offices, and high-net-worth individuals. With over 151 partners operating under a distinctive lockstep model, Trilegal is the largest equity partnership in the country. The firm retains over 1,200 professionals across Mumbai, Delhi, Bengaluru, and Gurugram offices.

Trilegal has consistently been recognised among India’s top-tier firms in leading legal directories such as Chambers & Partners (Asia Pacific and Global), Legal 500 Asia Pacific, and Benchmark Litigation. It has also earned several prestigious accolades, including being named Best Overall Law Firm by India Business Law Journal (IBLJ) 2025, Innovative Lawyers in Disputes & Crisis Management by the Financial Times (FT) Innovative Lawyers Asia-Pacific Awards in 2025, M&A Firm of the Year by IFLR Asia-Pacific in 2024, Law Firm of the Year by Deal Volume at the VCCircle Awards in 2024.

For more information, please get in touch with Prakruti Jani | Mob: +91-9867868976 | BD@trilegal.com.